Health Insurance (Accredited Pathology Laboratories–Approval) Amendment Instrument (No. 2) 2019 (Cth)

Health Insurance (Accredited Pathology Laboratories-–Approval) Amendment Instrument (No. 2) 2019

I, David Weiss, First Assistant Secretary, Medical Benefits Division, make the following instrument.

Dated   24 September 2019  

David Weiss

First Assistant Secretary, Medical Benefits Division, Department of Health

Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments  2

Health Insurance (Accredited Pathology Laboratories-Approval) Principles 2017            2

1  Name

This instrument is the Health Insurance (Accredited Pathology Laboratories–Approval) Amendment Instrument (No. 2) 2019.

2  Commencement

  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  Sections 1 to 4 and anything in this instrument not elsewhere covered by this table	The day after this instrument is registered.
2.  Schedule 1	The day after this instrument is registered.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in Column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 23DNA(1) of the Health Insurance Act 1973.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Health Insurance (Accredited Pathology Laboratories–Approval) Principles 2017

1  Schedule 1 (table Item 14 )

Repeal the item, substitute:

14 Requirements for Laboratories Reporting Tests for the National Cervical Screening Program (Second Edition 2019) 2019

2  Schedule 1 (table item 16)

Repeal the item, substitute:

16 Requirements for Transfusion Laboratory Practice (Fourth Edition 2019) 2019

3  Schedule 1 (at the end of the table)

Add:

22 Requirements for Validation of Self-Collected Vaginal Swabs for use in the National Cervical Screening Program (First Edition 2019) 2019

.